gastroenteropancreatic neuroendocrine tumours | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

21,582 results for “gastroenteropancreatic neuroendocrine tumours”

Lantheus gains FDA approval for Bravnetsa in GEP-NET

ITM-11 Demonstrates Superior Progression-Free Survival Compared to Everolimus in GEP-NETs

XTR008 Achieves Dramatic Progression-Free Survival Benefit in Advanced Gastroenteropancreatic Neuroendocrine Tumors

AlphaMedix Achieves All Primary Endpoints in Phase 2 Trial for Gastroenteropancreatic Neuroendocrine Tumors

FDA Accepts ITM's New Drug Application for 177Lu-edotreotide in Gastroenteropancreatic Neuroendocrine Tumors

ITM to Present Pancreatic Neuroendocrine Tumor Subgroup Analysis from Phase 3 COMPETE Trial at ENETS 2026

NUCLIDIUM's Copper-Based PET Tracer Shows Promise in Phase I/II Trial for Neuroendocrine Tumor Detection

Phase 2 Trial Shows 70% Response Rate for Novel Combination Therapy in Advanced Neuroendocrine Tumors

Nanopharmaceutics Completes Phase II Enrollment for Triapine Combination Therapy in Neuroendocrine Tumors

Lutetium-177 Dotatate Shows Promise in Neuroendocrine Tumors, Combination Strategies Explored

Page 1 of 131